| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | +14.3% |
| Cost of Revenue | $3.2M | -13.0% |
| Gross Profit | $10.6M | +26.4% |
| R&D Expense | $2.2M | -16.2% |
| SG&A Expense | $10.9M | -25.7% |
| Operating Income | -$2.4M | +72.3% |
| Interest Expense | $364K | -87.9% |
| Pre-tax Income | -$8.4M | +40.3% |
| Net Income | -$8.4M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $365K | -53.5% |
| Accounts Receivable | $1.7M | +12.9% |
| Inventory | $1.6M | -17.2% |
| Current Assets | $4.6M | +3.8% |
| Total Assets | $5.6M | -5.1% |
| Current Liabilities | $20.6M | -9.1% |
| Total Liabilities | $35.7M | -0.7% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | +64.4% |
| Financing Cash Flow | $1.9M | -71.4% |
| +40.3% |
| EPS (Basic) | -$0.56 | +66.6% |
| EPS (Diluted) | -$0.56 | +66.6% |
| Stockholders' Equity |
| -$32.0M |
| -1.7% |